
Cullinan Oncology LLC (CGEM)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 483.82M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 19.89
52W Low
$ 6.85
Dividend Yield
0.00%
Beta
-0.07
Technicals
50-Day MA
7.8019
200-Day MA
9.4518
52 Week High
19.89
52 Week Low
6.85
About CGEM
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.
Employees
111
Headquarters
Cambridge, MA
CEO
Mr. Nadim Ahmed
Latest News
CGEM Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - 더경남뉴스
8 hours ago • Google News